March 11, 2024 · Form 4 insider transaction
Nunes Anne bought 3,295 shares of Anika Therapeutics, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as option exercise and disclosed on an SEC Form 4, filed 1 day after the transaction.
Reflects the first vesting installment of RSUs granted on March 9, 2023.; Reflects the corrected Amount of Shares Beneficially Owned under Table I, Column 2 as reported in Form 3/A filed by the Reporting Person on January 12, 2024.; Includes 414 shares acquired under the Anika Therapeutics, Inc. Employee Stock Purchase Plan on November 14, 2023.